Some of these previous studies found enriched expression of B-cells, M2 macrophages, regulatory T-cells, CD8 + and CD4 + T-cells, and immune-checkpoints such as PD-L1 among IBC compared to non-IBC [11, 57–61]. This evidence concerns the gene CD8A and inflammatory breast carcinoma.